Strong beat in Q3, positive management commentary sees stock gain more than 9 per cent on Wednesday
Given the wider adoption of digital initiatives within the healthcare industry, Indegene plans to use the funds to accelerate its M&A (merger and acquisition) and global expansion plans
While several sectors like airlines and real estate are still reeling from the pandemic, here's is look at the winners and losers during the period
The company has repaid debt of about $490 million in 9MFY21; filings for 90 ANDAs await US FDA approval
Overall, the company saw decent growth in its product segments, led by cardio metabolic and vitamin-mineral-nutrients
He said the crisis itself presented the industry with several opportunities and allowed us to think differently
Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportunities
Policy makers in developing nations may not have a choice but to take what they can get - easily, cheaply and quickly
Sun Pharma on Monday said it has initiated Phase 2 clinical trial for a product being developed to treat patients with moderate to severe plaque psoriasis.
Margin expansion to support profits, clean regulatory track record to help sustain growth journey
The Phase 3 trial of another investigational Covid-19 vaccine developed by biotechnology company Novavax, has started enrolling adult volunteers, the US National Institutes of Health (NIH) announced
The world is looking at India as a beacon of hope to manufacture and supply the huge number of vaccines needed to tackle the pandemic
A group of scientists in the US, including an Indian-American from the prestigious Cleveland Clinic, have identified a potential new class of drugs that may prove effective in treating certain common types of blood and bone marrow cancers. First published in the latest edition of Blood Cancer Discovery, the decade long research which reports that a new pharmacological strategy to preferentially target and eliminate leukemia cells with TET2 mutations, was carried out by Jaroslaw Maciejewski and his collaborator Babal Kant Jha from the Cleveland Clinic Department of Translational Hematology & Oncology Research. Myeloid leukemias are cancers derived from stem and progenitor cells in the bone marrow that give rise to all normal blood cells. One of the most common mutations involved in driving myeloid leukemias are found in the TET2 gene, which has been investigated for the last decade by Maciejewski and Jha. In preclinical models, we found that a synthetic molecule called TETi76 was ..
Dr Reddy's Canada has filed an application on behalf of the consortium for Reeqonus (favipiravir) tablets for acute treatment of mild to moderate Covid-19 adult patients
Drug major Glenmark Pharma on Monday said it has received tentative approval from the US health regulator for anticoagulant Dabigatran Etexilate capsules
Regulatory safeguards to ensure quality and efficacy of drugs are a necessary pre-condition for effective competition between generic and branded drugs
Drug major Aurobindo Pharma said it has received final approval from the US health regulator for generic of Precedex injection, used for sedation of patients
Amazon is considering a nearly $100 million investment in India's Apollo Pharmacy, facing up to Reliance Industries and Tata Group in the country's fast-growing drug market, a report said
Oct growth rate was 9.6%; Most big corporates saw volumes drop in November
Moderna said it expects to have between 100 million and 125 million doses of its experimental Covid-19 vaccine available globally in the first quarter of 2021